Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transient effusive-constrictive pericarditis due to chemotherapy.

T Woods1, B Vidarsson, D Mosher

  • 1Department of Medicine, University of Wisconsin Medical School, Madison 53792-3248, USA.

Clinical Cardiology
|April 13, 1999
PubMed
Summary

Chemotherapy drugs like cytarabine and daunorubicin can cause effusive-constrictive pericarditis. This case report details a patient with acute myelogenous leukemia experiencing a temporary form of this condition due to treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Childhood-onset Takayasu arteritis: clinical presentation, challenges and disease course.

Pediatric rheumatology online journal·2025
Same author

Hohlraum Reheating from Burning NIF Implosions.

Physical review letters·2024
Same author

Alpha heating of indirect-drive layered implosions on the National Ignition Facility.

Physical review. E·2023
Same author

Safety of <i>Bifidobacterium breve</i>, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial.

Beneficial microbes·2022
Same author

HIV Care Engagement Among Trans Women of Color in San Francisco Bay Area Demonstration Projects: Findings from the Brandy Martell Project and TransAccess.

AIDS and behavior·2019
Same author

Social Media Research Strategy to Understand Clinician and Public Perception of Health Care Messages.

JDR clinical and translational research·2019

Area of Science:

  • Cardiology
  • Oncology
  • Pharmacology

Background:

  • Chemotherapeutic agents, including cytarabine and daunorubicin, are vital in treating acute myelogenous leukemia (AML).
  • These agents can have significant side effects, impacting various organ systems.
  • Pericardial disease is a known, though less common, complication of chemotherapy.

Observation:

  • A patient diagnosed with acute myelogenous leukemia developed effusive-constrictive pericarditis.
  • The condition presented during the course of chemotherapy treatment.
  • This specific presentation was observed in the context of standard-of-care AML therapy.

Findings:

  • The patient experienced transient effusive-constrictive pericarditis.
  • The pericarditis was directly attributed to the administration of chemotherapeutic agents.

Related Experiment Videos

  • This represents the first documented case of transient chemotherapy-induced effusive-constrictive pericarditis.

    • Implications:

    • Highlights a rare but serious cardiac complication of AML chemotherapy.
    • Suggests the need for heightened cardiac monitoring in patients receiving cytarabine and daunorubicin.
    • Informs clinical practice regarding potential cardiotoxicity of specific chemotherapeutic regimens.